INHA and seminoma: Nuclear phospho-SMAD2/3 signal was present in all seminoma samples, indicating active activin/TGFβ signaling in these tumors, however, a subset of seminoma specimens exhibited expression of betaglycan or the inhibin alpha subunit, both of which block activin signaling and are normally only produced in somatic cells (87).